Abstract
Multiresistant Enterobacter cloacae infection in six premature infants was eradicated with intravenous ciprofloxacin (10 mg/kg/day). Bacterial resistance did not develop. Adequate plasma ciprofloxacin concentrations were achieved in all treated patients. No clinical evidence of side effects was observed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chapman S. T., Speller D. C., Reeves D. S. Resistance to ciprofloxacin. Lancet. 1985 Jul 6;2(8445):39–39. doi: 10.1016/s0140-6736(85)90083-2. [DOI] [PubMed] [Google Scholar]
- Isaacs D., Slack M. P., Wilkinson A. R., Westwood A. W. Successful treatment of Pseudomonas ventriculitis with ciprofloxacin. J Antimicrob Chemother. 1986 Apr;17(4):535–538. doi: 10.1093/jac/17.4.535. [DOI] [PubMed] [Google Scholar]
- McClain J. B., Rhoads J., Krol G. Cerebrospinal fluid concentrations of ciprofloxacin in subjects with uninflamed meninges. J Antimicrob Chemother. 1988 Jun;21(6):808–809. doi: 10.1093/jac/21.6.808. [DOI] [PubMed] [Google Scholar]
- Modi N., Damjanovic V., Cooke R. W. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child. 1987 Feb;62(2):148–151. doi: 10.1136/adc.62.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scully B. E., Neu H. C., Parry M. F., Mandell W. Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa. Lancet. 1986 Apr 12;1(8485):819–822. doi: 10.1016/s0140-6736(86)90937-2. [DOI] [PubMed] [Google Scholar]